Delay of migrating leukocytes by the basement membrane deposited by endothelial cells in long-term culture  by Burton, Victoria J. et al.
E X P E R I M E N T A L C E L L R E S E A R C H 3 1 7 ( 2 0 1 1 ) 2 7 6 – 2 9 2
ava i l ab l e a t www.sc i enced i r ec t . com
www.e l sev i e r . com/ loca te /yexc rResearch Article
Delay of migrating leukocytes by the basement membrane
deposited by endothelial cells in long-term cultureVictoria J. Burton, Lynn M. Butler, Helen M. McGettrick, Phil C. Stone, Hannah C. Jeffery,
Caroline O. Savage, G. Ed Rainger, Gerard B. Nash⁎
Centre for Cardiovascular Sciences and MRC Centre for Immune Regulation, College of Medical and Dental Sciences,
The University of Birmingham, Birmingham, B15 2TT, UKA R T I C L E I N F O R M A T I O N⁎ Corresponding author. Department of Physiol
UK. Fax: +44 121 414 6919.
E-mail address: g.nash@bham.ac.uk (G.B. Na
Abbreviations: EC, endothelial cell; BM, base
0014-4827 © 2010 Elsevier Inc.
doi:10.1016/j.yexcr.2010.10.022
Open access under A B S T R A C TArticle Chronology:
Received 20 April 2010
Revised version received
25 October 2010
Accepted 27 October 2010
Available online 4 November 2010We investigated the migration of human leukocytes through endothelial cells (EC), and particularly
their underlying basement membrane (BM). EC were cultured for 20 days on 3 μm-pore filters or
collagen gels to forma distinct BM, and then treatedwith tumour necrosis factor-α, interleukin-1β or
interferon-γ. Neutrophil migration through the cytokine-treated EC and BMwas delayed for 20-day
compared to 4-day cultures. The BM alone obstructed chemotaxis of neutrophils, and if fresh ECwere
briefly cultured on stripped BM, there was again a hold-up inmigration. In studies with lymphocytes
andmonocytes,we could detect little hold-up ofmigration for 20-day versus 4-day cultures, in either
the filter- or gel-based models. Direct microscopic observations showed that BM also held-up
neutrophil migration under conditions of flow. Treatment of upper and/or lower compartments of
filters with antibodies against integrins, showed that neutrophil migration through the endothelial
monolayer was dependent on β2-integrins, but not β1- or β3-integrins. Migration from the
subendothelial compartment was supported by β1- and β2-integrins for all cultures, but blockade
of β3-integrin only inhibited migration effectively for 20-day cultures. Flow cytometry indicated
that there was no net increase in expression of β1- or β3-integrins during neutrophil migration, and
that their specific subendothelial function was likely dependent on turnover of integrins during
migration. These studies show that BM is a distinct barrier to migration of human neutrophils,
and that β3-integrins are particularly important in crossing this barrier. The lesser effect of BM on
lymphocytes and monocytes supports the concept that crossing the BM is a separate, leukocyte-
specific, regulated step in migration.
© 2010 Elsevier Inc. Open access under CC BY-NC-ND license.Keywords:
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During inflammatory responses, all major classes of leukocytes
may be recruited from the blood, although typically neutrophils
are the first to arrive in tissue, with monocytes and lymphocytes
appearing later. Experimentally, endothelial cells (EC) treatedogy, College of Medical and
sh).
ment membrane
CC BY-NC-ND license.with inflammatory cytokines such as tumour necrosis factor-α
(TNF) and interleukin-1β (IL-1) support adhesion andmigration of
all these leukocytes [1–4]. In flow, leukocytes are first captured by
specialised fast-acting endothelial receptors such as selectins or
vascular cell adhesion molecule-1 (VCAM-1), and roll on the
endothelial surface [5,6]. Chemokines and lipid-derived agents areDental Sciences, The University of Birmingham, Birmingham, B15 2TT,
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receptors. These cause rapid activation of leukocyte integrins
which support immobilisation, followed by migration across and
through the endothelial monolayer in minutes [7–10]. A propor-
tion of leukocytes are believed to migrate through endothelial
cells, but for themajority penetration of themonolayer is via inter-
cellular junctions [11]. Intercellular migration appears to be
modulated by ligation of endothelial receptors concentrated in
that area, including CD31 [12].
While the mechanisms supporting adhesion to the endothelial
surface and migration through it have been widely studied, less is
known about the kinetics and mechanisms of migration under the
endothelial cells and through the basement membrane (BM). In
mice it has become clear that transit of neutrophils through the BM
is a separately regulated stage in migration in vivo [13,14]. The
only study of migration of human leukocytes through BM to date
was performed by Huber and Weiss, who demonstrated that over
about 20 days, cultured EC laid down a BM with content,
morphology and permeability comparable to that seen in vivo
[15]. Neutrophils could migrate through the endothelial mono-
layers and its BM, into an underlying collagen gel, when a
chemotactic gradient was applied from below. Interestingly,
neutrophils appeared to be delayed above the BM for some
minutes before migrating into the gel, although no comparison
wasmade to behaviour observedwith short-term cultures without
complete BM. Using comparable long-term cultures on solid
substrate, we found that time of culture and contact with BM
modified the ability of EC themselves to recruit neutrophils, but
that nevertheless the BM laid down over 20 days (but not 4 days)
modified adhesive andmigratory functions of neutrophils [16–18].
Our model did not allow studies of migration through, rather than
on, the matrix laid down at different times, and none of the above
studies evaluated migration of lymphocytes or monocytes on or
through BM.
The involvement of β2-integrins in the initial stages of
immobilisation and transendothelial migration has been demon-
strated for all the major leukocyte subsets [2,8,9,19–21], but the
roles of β1- and β3-integrins in migration are less clear. Recent
studies have suggested that integrin ligation is not absolutely
required for migration through tissue matrix [22], but this is
unlikely to be the case for moving under EC and through BM.
Indeed, in mice neutrophils migration through the BM required
upregulation of β1-integrins [13,14]. We previously found that
pre-treatment of neutrophils with function-blocking antibodies
against β1- or β3-integrins had no effect on the ability to cross
endothelial monolayers or motility underneath them in short-
term cultures [23]. However, neutrophil β1-integrins did influence
adhesion to BM from 20-day cultures [17], and leukocyte integrins
of each of these families are capable of binding matrix proteins
[24]. Thus, evaluation of the roles of different integrins in
migration through the subendothelial space requires models
where realistic BM is present. Moreover, the leukocytes need to
have previously undergone transendothelial migration, because
behaviour of leukocytes depends on their prior adhesion/migra-
tion history. For instance, in mice, the upregulation of β1-integrin
alluded to above, was dependent on ligation of CD31 during the
transendothelial migration phase [13]. We and others have shown
that human neutrophils also alter their motility and adhesive
properties after they migrate through endothelial monolayers
[16,23,25].To clarify the effects of BM on the kinetics of migration of
human leukocytes, and to investigate which integrin classes were
required for the later stages of migration, we adapted our system
for examining recruitment by long-term endothelial cell cultures
[16]. EC were cultured on 3 μm pore filters or on collagen gels, so
that we could study penetration of BM. Transmigration was
studied over prolonged periods in a static system, and filters were
incorporated in a novel flow chamber [26], to allow direct
observation of migration through the whole construct over shorter
periods under flow.We found that the deposited BM represented a
significant obstruction tomigrating neutrophils, but that this effect
was much less marked for lymphocytes or monocytes. In the case
of neutrophils, β2-integrins dominated the initial stage of
transendothelial migration. While both β1- and β2-integrins
influenced subendothelial migration, this was not specific to
long-term cultures. However, prolonged endothelial culture
revealed a specific role for β3-integrins in migration on and
through fully-formed BM.Materials and methods
Isolation of leukocytes
Venous blood was drawn from healthy volunteers and transferred
into tubes containing K2EDTA (1.6 mg/ml final concentration)
(Sarstedt, Leicester, UK). Mononuclear cells and neutrophils were
isolated using a 2-step density gradient as previously described
[27,28] and washed twice in medium 199 (M199; Gibco Invitrogen
Compounds, Paisley, UK) supplemented with 0.15% bovine serum
albumin (culture-tested BSA; Fraction IV; Sigma-Aldrich, Poole, UK).
When desired, lymphocytes were prepared frommononuclear cells
by panning on culture plastic to remove contaminating monocytes.
Monocytes were isolated as described [29]. Dextran (1 ml 6%
w/v MW 500 kDa, in phosphate-buffered saline, PBS; Sigma) was
added to 10 ml EDTA-blood, the tube was placed at an angle of 45°
from the vertical, and red cells were allowed to sediment for 1 h. The
leukocyte-rich supernatant was retrieved and placed on top of 3 ml
Nycoprep 1068 medium (Amersham Biosciences, Chalfont St Giles,
UK), and centrifuged at 400 g for 15 min. The plasma-rich top was
discarded and the middle layer which was rich in monocytes was
decanted, washed twice in Ca++/Mg++-free PBS with 0.15%
BSA, and resuspended in M199 withBSA. Leukocyteswere counted
using a Coulter Counter (Coulter Electronics Ltd., Essex, UK) and
adjusted to a final desired concentration (0.5 to 2×106/ml).
Endothelial cell isolation and culture
Human umbilical vein endothelial cells (HUVEC) were isolated
from umbilical cords following maternal consent as previously
described [30] and cultured in M199 supplemented with 20%
heat-inactivated fetal calf serum (FCS), 2.5 μg/ml amphotericin B,
1 μg/ml hydrocortisone, 10 ng/ml epidermal growth factor (all
from Sigma-Aldrich) and 35 μg/ml gentamycin (Gibco Invitrogen
Compounds) until confluent. Primary HUVEC were dissociated
using trypsin/EDTA (Sigma-Aldrich) and seeded on uncoated
low-density 3.0 μm pore polycarbonate Transwell filters (which
were placed in matching plates; BD Pharmingen, Oxford, UK) or
collagen gels. To form collagen gels, type 1 collagen dissolved in
0.6% acetic acid (2.15 mg/ml; First Link Ltd., West Midlands, UK)
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The pH was neutralised by the addition of 0.18 ml 1 N NaOH, and
1 ml was dispensed into a 6-well plate and allowed to gel at 37 °C.
The gel was then equilibrated with HUVEC culture medium for
48 h before seeding with HUVEC. Seeding density was chosen to
yield confluent monolayers within 24 h. After culture for 2 to
20 days, HUVEC were stimulated with 0, 1 or 100 U/ml tumour
necrosis factor α (TNF) or 50 pg/ml interleukin-1β (IL-1; both from
Sigma-Aldrich) for 4 h before assays of neutrophil migration. For
studies of mononuclear cells, HUVEC cultured on gels were treated
with TNF (100 U/ml) for 4 h for direct comparison to neutrophils; for
studies using filters, HUVEC were stimulated with TNF (100 U/ml)
plus interferon-γ (IFNγ; 10 ng/ml; Peprotech Inc., London, UK) for
24 h before assay to optimise transmigration [31].
In some experiments, after 4 or 20 days of culture HUVEC were
stripped from their underlying substrates as previously described
[16], to expose the intact underlying basement membrane on the
filter. The ECmonolayers were detached by addition of phosphate-
buffered saline (PBS) containing 0.5% Triton X-100 and 20 mM
NH4OH (all Sigma) pre-warmed to 37 °C. Lysis and detachment of
cells was observed microscopically, and when complete, the
surface was gently rinsed 5 times with PBS. When required,
fresh HUVEC were seeded onto the 4-day or 20-day matrices and
cultured for 2 days before treatment with TNF as above. To observe
the morphology of deposited matrix, stripped substrates were
fixed, processed and examined by scanning electronmicroscope as
described [16].
Migration of leukocytes through endothelial cells and filters
under static conditions
Leukocyte adhesion and transmigration was assessed using 24-
well format or 6-well format Transwell filters in matching plates.
Medium was removed from HUVEC and filters were transferred to
wells that had been previously treated with poly(2-hydroxyethyl
methacrylate) to prevent cell adhesion to the bottom of the well
[32]. M199+BSA was added to the lower chamber and leukocyte
suspension in M199+BSA was added to the upper chamber
(200 μl for 24-well or 1500 μl for 6-well formats; 1×106/ml for
neutrophils, 2×106/ml for mononuclear cells). Leukocytes were
allowed to settle, adhere and transmigrate for the desired time
period in an incubator maintained at 37 °C, 5% CO2. Migration was
stopped at the chosen time by transferring the filter into a clean
well. Leukocytes in the original lower chamber were resuspended
and removed, the chamber was rinsed with M199+BSA, and the
two samples pooled (fraction 1). Leukocytes in the chamber above
the filter were resuspended and removed, the chamber was rinsed
with M199+BSA, and these two samples also pooled (fraction 2).
Filters were then fixed and stained with 2% gluteraldehyde
containing 1 μg/ml bisbenzamide (fluorescent nuclear stain;
Sigma-Aldrich) for 15 min. Filters were cut out and mounted
directly onto microscope slides and coverslips were mounted
using Vectorshield (Vector Labs, Peterborough, UK).
Leukocytes in fractions 1 and 2 were counted using a Coulter
counter. The numbers of leukocytes adherent above (fraction 3) or
below (fraction 4) the filter were counted using a fluorescence
microscope. Leukocytes in ten fields of a known area were
counted. The total number was determined by multiplying the
average number per field by the known area of the filter divided by
the field area. All numbers were expressed as a percentage of thenumber of leukocytes added. The percentage of transmigrated
cells was calculated by adding fractions 1 and 4. The percentage of
adherent cells was calculated by subtracting fraction 2 from 100%.
When evaluating migration of mononuclear cells, the Coulter
counter could distinguish between distinct populations of smaller
lymphocytes and larger monocytes. When counting the leukocytes
adherent below the filter, nuclear morphology was used to
estimate the numbers of lymphocytes and monocytes (small
round nuclei for lymphocytes, larger kidney-shaped nuclei for
monocytes). In this way we obtained estimates of the percentage
migration for the two cells types, as well as the more accurate
value for the whole population.
When desired, interleukin-8 (IL-8; 10 ng/ml) or stromal-
derived factor 1α (SDF1α; 80 ng/ml) (both R&D Systems,
Abingdon, UK) was added to the lower wells immediately before
addition of leukocytes, to provide an additional chemotactic
stimulus. In some of these experiments, stripped filters (i.e.,
coated with matrix but not EC) were used, and migration of
neutrophils through matrix alone was quantified.
Migration of leukocytes through endothelial cells into
collagen gels under static conditions
HUVEC on collagen gels were washed with M199+BSA to
remove residual cytokines, and leukocytes (2 ml; 0.5×106/ml for
neutrophils, 1×106/ml for mononuclear cells) were added for
10 min. Non-adherent cells were removed from the HUVEC by
gentlewashingwithmedium, and phase-contrast video-microscope
recordings were made 0.25 h, 1 h, 3 h and 24 h after the original
addition of leukocytes. Five video-fields were recorded. In each field,
images were first recorded at the endothelial surface, and then
recordings were made as the microscope was focussed gradually
down in 100 μm steps. Cells visible with the endothelial monolayer
were counted and divided into those which were phase-bright
(above EC) and those which were phase-dark (just below EC). Cells
within each 100 μm step were counted as they came into focus;
these cells were phase-bright. The focal depth of the gels was
approximately 300 μm. For a given field of known dimensions, the
number of cells counted in the different layers was added and
expressed as total adherent cells/mm2. The numbers of migrated
cells just below the endothelium, or migrated into the gel
were expressed as a proportion of the total adherent cells. The
values were averaged for the five fields analysed in each
experiment. All manipulations of gels and microscopy were carried
out at 37 °C.
Adhesion and migration of neutrophils through endothelial
monolayers under flow
Transwell filters (6-well format) coated with HUVEC were cut out
and placed on a coverslip, which was incorporated into a bolt-
together, parallel-plate, flow chamber as previously described
[26]. The flow chamberwas placed on the stage of a phase-contrast
video-microscope which was enclosed in a chamber at 37 °C, and
attached to a perfusion system [8]. HUVEC were perfused with
cell-free medium, and then neutrophils were perfused for 4 min,
followed by washout with cell-free medium. Flow rate was chosen
to exert a wall shear stress of 0.1 Pa (1 dyn/cm2) throughout. Video
recordings were made of 5 fields along the centreline of the flow
channel following a 2 minute washout, and at chosen intervals
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allow analysis of migration velocities of neutrophils (see the
following discussion). During the later recordings, images were
recorded not only of neutrophils interacting with HUVEC on the
upper surface of the filter, but also of neutrophils attached to the
back of the filter and to the coverslip beneath the filter. This was
achieved by focussing the microscope down 10 μm from the top of
the filter, to observe the back, and then a further distance
(typically ≥10 μm) to view the surface of the coverslip.
The video recordings of adhesion and migration of the
neutrophils were digitised and analysed offline using Image-Pro
Plus software (DataCell Ltd., Finchampstead, UK) as described [23].
An example is shown in the Supplemental video. Three classes of
adherent neutrophils on HUVECwere counted: (i) rolling adherent
cells (which were spherical, and rotated steadily over the surface
at a velocity ~10 μm/s); (ii) stably-adherent ‘activated’ neutrophils
migrating on the top of the endothelial monolayer, which were
phase-bright with distorted shape; and (iii) transmigrated
neutrophils migrating underneath the monolayer, which were
phase-dark. The numbers of neutrophils adherent to the back of
the filter and to the coverslip were also counted (see Supplemental
Fig. 1). Counts were converted to cells per mm2 using the
calibrated microscope field dimensions, and the numbers in all
categories added to give the total number of adherent neutrophils.
The percentages of adherent neutrophils in each category were
then calculated.
The velocities of phase-dark neutrophils migrating under-
neath HUVEC were measured by digitising a sequence of
images 1 min apart. In each digitised image, cells were outlined
and the position of their centroid determined. Movement was
followed for 5 min for ~10 cells, and migration velocity (μm/min)
was calculated as the average distance moved by the centroid of a
cell per minute.
Adhesion of neutrophils to stripped endothelial matrix and
purified proteins
HUVECwere cultured in 6-well plates for 4 or 20 days and then the
cells were stripped from their underlying substrates as above. The
plates were placed on the stage of a phase-contrast video-
microscope enclosed at 37 °C. Neutrophils (2 ml) were treated
with IL-8 (10 ng/ml), added to the wells and allowed to settle for
5 min. Non-adherent cells were removed by washing the surface
twicewithM199+BSA and a series of 5 separate video-fields were
recorded. Neutrophils in each field were counted and averaged,
and the average number adherent was converted to cells/mm2
using the known field dimensions. For comparison, the same assay
was carried out using six-well tissue culture plates coated at 37 °C
for 24 h with solutions of the following proteins at 0.2 μg/ml in
PBS: laminin purified from human placenta (Chemicon Europe
Ltd., Chandlers Ford, UK); vitronectin from human serum (Sigma);
fibronectin from human serum (Sigma); collagen type IV from
human placenta (Sigma). Residual protein-binding sites were then
blocked with PBS containing 1% bovine serum albumin (BSA,
culture-tested; Sigma) at 37 °C for 1 h.
Antibody treatment and inhibitory agents
The following function-blocking monoclonal antibodies (mAb)
were used (all at a concentration of 10 μg/ml, and mouse IgG1unless stated): mAb13 against β1-integrin/CD29 (rat IgG2a;
Becton Dickinson, Oxford, UK); R6.5E against the β2-integrin/
CD18 (a gift fromDr. M. Robinson, Cell Tech, Slough, UK); and SZ21
against the β3-integrin/CD61 (Immunotech, Marseille, France).
Control antibodies were mouse IgG1 (Dako, Ely, Cambridgeshire,
UK), rat IgG2a (Southern Biotech Associates, Alabama, USA).
Neutrophils were incubated with antibodies at 37 °C for 10 min
prior to addition to the upper chamber of Transwell filters,
perfusion through the flow chamber or addition to coated surfaces.
In some experiments, mAbwere added to the lower chamber only,
or to the lower chamber as well as to neutrophils. Antibodies were
present throughout migration through Transwell filters, but not
after washout of the flow chambers. In some experiments RGDS
peptide (Arg-Gly-Asp-Ser; 0.5 mM; Sigma) was added to neutro-
phils immediately before analysis.
Surface expression of integrins by neutrophils
To examine changes in integrin surface expression during
migration, neutrophils were added to Transwell filters coated
with HUVEC and collected from the upper or lower chambers after
2 h. Aliquots from these samples, and an aliquot of the original cell
suspension, were incubated on ice for 30 min with one of the
following mAb each at 10 μg/ml: PE-conjugated anti-β1-integrin
(P5D2; R&D Systems, Abingdon, UK); FITC-conjugated anti-β2-
integrin (212701; R&D Systems); unconjugated anti-β3-integrin
(SZ21; Immunotech). Neutrophils incubated with SZ21 were
centrifuged for 4 min and the pellet resuspended and incubated
on ice for 30 min with FITC-conjugated goat anti-mouse IgG1
(Dako). All cells were finally centrifuged for 4 min at 2000 g then
resuspended in ice-cold PBS containing 2% BSA. In separate
experiments to examine possible internalisation of integrins
during migration, neutrophils were labelled with non-blocking
unconjugated anti-β1-integrin (419127; R&D) or unconjugated
anti-β3-integrin (256809; R&D Systems), and washed twice
before addition to Transwell filters coated with HUVEC. Cells
were collected from the upper or lower chambers after 2 h. The
collected cells, and an aliquot of the originally-labelled cells, were
incubated with secondary antibody and washed as above. Samples
were analysed using a Coulter XL flow cytometer (Beckman
Coulter, High Wycombe, UK) and data expressed as median
fluorescence intensity (MFI).
Surface ELISA for stripped substrates
ELISA were carried out using EC grown in 96-well plates (Falcon;
Becton Dickinson) for 4 or 20 days and then stripped as above. The
following primarymAbwere added to surfaces for 1 h at 37 °C: anti-
vitronectin (0.8 μg/ml; clone VIT-2; Abcam, Cambridge, UK); anti-
laminin (0.1 μg/ml; clone HL-4H3 raised against the P1 pepsin-
resistant fragment of laminin from human placenta; Calbiochem,
Nottingham, UK); anti-laminin α4-subunit (0.01 μg/ml; clone 3H2,
Santa Cruz Biotechnology, Inc., Heidelberg, Germany); and anti-
laminin α5-subunit (2 μg/ml clone 3H2, Santa Cruz). Surfaces
were washed with PBSA and secondary, horseradish peroxidase-
conjugated, goat-anti-mouse antibody (1/2000; Dako) was added
for 1 h at 37 °C, and washed out with PBSA. Peroxidase substrate
(1,2-phenylenediamine dihydrochloride; Dako) was added for
7 min and the reaction stopped by the addition of 100 μl of 1 M
H2SO4. The colour product absorbance was measured at 490 nm
280 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 7 ( 2 0 1 1 ) 2 7 6 – 2 9 2using a plate reader, and the signal obtained using a non-specific
control antibody (mouse IgG; Dako) was subtracted.
The antibody concentrations were chosen after titration in
ELISA on purified vitronectin or laminin from human placenta,
coated in plates at 0.2 μg/ml, as were used in the neutrophil
adhesion assays described above. It was notable that a much
higher concentration of anti-laminin α5-subunit was required to
obtain comparable signals to the other antibodies for this mixed
laminin type.Fig. 1 – Comparison of transmigration of neutrophils through HUV
then treated with TNF or IL-1. A,B. Scanning electron micrographs
20 days. C. Transmigration after 2 h through HUVEC treated with di
HUVEC treated with 100 U/ml TNF. E. Comparison of transmigration
F. Effect of adding IL-8 to the bottomwell on transmigration throug
from 3 to 7 independent experiments. In C, ANOVA showed a signific
In D, ANOVA showed a significant effect of culture duration (p<0.
significant effects of culture duration (p<0.01). *p<0.05, **p<0.0Statistical analysis
In all experiments, short-term (2-day or 4-day) and long-term
(20-day) cultures of HUVECwere tested on the same day using the
same leukocyte isolate. Although the HUVEC themselves were not
from the same primary isolates, these comparisons were consid-
ered as paired. Effects of multiple treatments or of time were
tested using analysis of variance (ANOVA). Comparisons of
individual treatments were done by paired t-test.EC which had been cultured for 4 ( ) or 20 ( ) days and
of matrix deposited by EC on filters after culture for 4 days or
fferent doses of TNF. D. Time course of transmigration through
through HUVEC treated with TNF (100 U/ml) or IL-1 (50 pg/ml).
h HUVEC treated with TNF (100 U/ml). Data are the mean±SEM
ant effect of TNF dose (p<0.01) and culture duration (p<0.01).
05) and assay time (p<0.01). In E and F, ANOVA showed
1 compared to 4-day by paired t-test.
Fig. 2 – Comparison of transmigration of neutrophils through
HUVEC cultured for different durations undisturbed or
re-seeded on matrix deposited over different periods. HUVEC
were cultured for 4 or 20 days, and then stripped from the
underlying matrix. Fresh HUVEC were added to the matrix and
cultured for 2 days. Control HUVEC were cultured undisturbed
in parallel for 6 or 22 days. The final ‘age’ of matrices was
therefore 6 or 22 days. All HUVEC were treated with 100 U/ml
TNF for 4 h before neutrophils were added to the upper
chamber and allowed to transmigrate for 2 h. Data are the
mean±SEM from three (undisturbed) or five (re-seeded)
experiments. ANOVA showed a significant effect of matrix age
on transmigration (p<0.01). *p<0.05 compared to 6-day
matrix by paired t-test.
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Effects of BM laid down by HUVEC on porous filters on
migration of neutrophils
Figs. 1A,B shows scanning electron micrographs of the matrix that
had been deposited by HUVEC on 3 μm-pore filters after 4 or
20 days of culture. In agreement with previous observations [16],
there were discrete fibrils after 4 days, but a substantial sheet of
material which masked the pores after 20 days. In initial experi-
ments, the proportion of neutrophils migrating through HUVEC
in 2 h increased with an increasing dose of TNF, but there was
a significant reduction in migration through 20-day compared to
4-day cultures (Fig. 1C). The time course of migration was
examined for HUVEC treated with 100 U/ml TNF. Migration
through 20-day cultures was delayed compared to 4-day cultures
during the period up to 2 h but, after 24 h, transmigration had
caught up for the 20-day cultures (Fig. 1D). We next tested the
stimulus-specificity of the delay by comparing migration through
HUVEC treated with TNF or IL-1. With each stimulus, migration
through the 20-day cultures was reduced compared to 4-day
cultures (Fig. 1E). The above results did not arise because less
neutrophils adhered to the longer-term cultures. Gathering data
from experiments using 2 h incubations throughout the study, we
found that adhesion of neutrophils to day-20 HUVEC treated with
100 U/ml TNF was 95%±2% of adhesion to day-4 HUVEC, whereas
transmigration through the endothelium and filter was 70±3% of
the value for day 4 (mean±SEM, n=98).
To address the nature of the hold-up further, we added IL-8
to the bottom well of TNF-stimulated HUVEC, to provide an
EC-independent chemotactic factor. While IL-8 increased the
proportion of neutrophils transmigrating, again there was reduced
migration through 20-day cultures compared to 4-day cultures
(Fig. 1F). We also stripped EC and tested migration to IL-8 through
filters coated with matrix alone. We found that fewer neutrophils
underwent chemotaxis through 20-day BM compared to 4-day
matrix (21.0±4.7% vs. 50.7±7.1% of cells added; mean±SEM from
5 paired experiments; p<0.05 by paired t-test). Thus, the deposited
BM acted as a barrier on its own.
To further rule out effects arising from prolonged endothelial
culture itself, we cultured fresh HUVEC for 2 days on the matrix
that remained after stripping of 4- or 20-day cultures. Control 6- and
22-day cultures of HUVEC that had not been stripped were tested in
parallel. Levels of neutrophil transmigration were effectively the
same for EC that had been left on their original matrix and for EC that
had been seeded onto pre-formed matrix, and transmigration was
reduced in either case for 22-day versus 6-day matrices (Fig. 2).
Effects of BM laid down by HUVEC on porous filters on
migration of mononuclear cells
When mononuclear cells were settled on HUVEC that had been
treated with TNF+IFN, there were no significant differences
between adhesion to short-term or long-term cultures (data not
shown). Migration was much less efficient than for neutrophils,
and so it was quantified at 2, 4 or 24 h, and not at earlier time
points. Judged overall, we did not detect any difference in
migration through 4-day or 20-day cultures (Fig. 3A). In these
experiments, monocytes represented 15±1% (mean ± SEM from3 experiments) of the mononuclear cells judged by cell volume
measured by a Coulter counter. When we estimated lymphocyte
and monocyte migration separately, monocytes migrated more
rapidly than lymphocytes, but long-term culture did not hold-up
migration in either case (Figs. 3B,C).
In previous studies, we have pointed out that lymphocytes can
migrate across endothelial monolayers in minutes, but take many
hours to cross endothelial/filter constructs [33]. Given the very low
levels of lymphocyte transmigration detected here in the first
hours, it is possible that any delay induced by the BM would be
undetectable because the delay in crossing the filter itself was
much greater and independent of culture duration. We attempted
to reduce this delay by adding SDF1α to the bottomwell. The level
of transmigration through 2-day cultures after 2 h was increased
(e.g., 18.1±2.7% ofmononuclear cells migrated) but there was still
no reduction detected for 20-day cultures (17.4±9.1% of mono-
nuclear cells transmigrated; mean±SEM; n=3).
Effects of BM laid down by HUVEC on collagen gels on
migration of leukocytes
To allow more direct observations of migration through BM, and to
avoid potential effects of an obstructive structure beneath, EC were
grown on collagen gels for different periods. The various leukocytes
were allowed to settle on this surface and microscopic observations
weremadeat chosen times.A similarnumber of neutrophils adhered
to short-term (2-day) or long-term (20-day) cultures of EC on
collagen gels, after treatment with TNF (743±67 vs. 622±92 cells/
Fig. 3 – Comparison of transmigration of (A) mononuclear cells,
(B), lymphocytes, (C), monocytes, through HUVEC which had
been cultured for 4 ( ) or 20 days ( ) and then treated
with TNF+IFNγ. Data are the mean±SEM from 3 independent
experiments inwhichmigrationwas analysed after 2, 4 and 24 h.
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a large proportion of neutrophils migrated through TNF-treated
endothelial monolayers within 15 min, and were phase-dark and
spread just below the monolayer at that time (Fig. 4A). For 2-day
cultures, by 1 h the great majority of migrated neutrophils had
entered the gel (Fig. 4B). In comparison, for 20-day cultures, more
cells remained immediately below the endothelial monolayer, and
less in the gel, at the 1 and 3 h time points (Figs. 4A,B). By 24 h
essentially all migrated neutrophils were in the gel in all cases. Few
neutrophils remained above the endothelial monolayer.
For isolated lymphocytes, total adhesion was again similar for
2-day or 20-day cultures after treatment with TNF (308±27 vs.
288±49 cells/mm2 respectively; mean±SEM from 4 experi-
ments). Migration through both cultures was evident within15 min, but even at 1 h nearly all migrated cells were still just
below the monolayer (Figs. 4C,D). After 3 h, a small proportion of
lymphocytes had migrated into the gel, and this proportion was
slightly but significantly less for 20-day cultures than 2-day
cultures. By 24 h, a greater proportion had migrated into the gel,
and migration for the 20-day cultures had caught up with the
2-day cultures. In contrast to neutrophils, significant propor-
tions of lymphocytes remained adherent above the monolayer or
just below it throughout the 24 h period. We have previously
reported the difference in the migratory capability of the two cell
types for short-term cultures [33]. Separately, we also tested
mixed mononuclear cells in the gel-based model. In this case, the
kinetics of leukocyte migration were very similar for the 2-day
or 20-day cultures, and at 3 h the lag in entry into the gel for the
20-day cultures was not evident (Figs. 4E,F). The data suggest
there was even less delay for monocytes than lymphocytes. To
test this independently, we isolated monocytes from blood and
tested their migration through TNF-treated HUVEC. Monocytes
efficiently crossed the endothelial monolayer (Fig. 4G). They
entered the collagen more efficiently than lymphocytes initially,
but over 24 h the proportions entering were similar for the two
cell types (Fig. 4H). There was no significant delay in monocyte
entry for 20-day versus 4-day cultures. Results with the mono-
cytes tended to be more variable than other populations studied,
and overall, there were no statistically significant differences in
behaviour for the 4-day or 20-day cultures.
Delay of neutrophil migration by the BM directly observed
under flow
Since delay ofmigrationwas onlymarked for neutrophils, wemade
direct observations of flowing neutrophils as they adhered and
migrated first through HUVEC and then through the filters. The
numbers of neutrophils captured by TNF-treated HUVEC were
similar for 4-day or 20-day cultures (1243±189 vs. 1188±
176 cells/mm2/106 perfused respectively; mean±SEM from 7
experiments). The percentages rolling, stationary or transmigrat-
ing through the endothelial monolayer were also similar, with
slightly more efficient transmigration through the endothelial
monolayer for the 20-day cultures (Fig. 5A). However, we noted
that while neutrophils soon appeared below the filter for 4-day
cultures, it took much longer for this to happen for the 20-day
cultures (Fig. 5B). We also noted that there was a tendency for
neutrophils to migrate more slowly under the older endothelial
monolayer; velocity=10.5±0.4 μm/min vs. 8.3±0.3 μm/min for
4-day and 20-day cultures respectively (mean±SEM of means
from 3 experiments; p<0.01 by paired t-test). This slower migra-
tion is consistent with our previous report using EC grown on
culture plastic and analysed under static conditions [16]. Thus, the
formed BM modified neutrophil migration and acted as a barrier
to progress under conditions of flow as well as in static assays.
Roles of neutrophil integrins during migration through
endothelial cells and BM
We investigated whether requirement for specific integrin subsets
might explain the hold-up of neutrophils migrating through BM.
The effects of function-blocking antibodies against integrins were
tested for neutrophils allowed to migrate for 2 h through HUVEC
that had been cultured on filters and treated with 100 U/ml TNF.
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Fig. 5 – Comparison of behaviour of neutrophils adhering
from flow to TNF-treated HUVEC cultured for 4 or 20 days.
A. Percentageof adherentneutrophils rolling, stationaryadherent
or transmigrated through the monolayer after 11 min.
B. Percentage of adherent neutrophils that transmigrated
through the filterover time.HUVECwere cultured for4or20 days,
treated with 100 U/ml TNF for 4 h and transferred to a flow
chamber before perfusion of neutrophils for 4 min, followed by
washout. Timezerowas the start of neutrophil perfusion.Data are
the mean±SEM from 4 experiments. In B, ANOVA showed a
significant effect of culture duration onmigration (p<0.01).
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adhesion by about 30% but caused a much greater reduction in
transmigration after 2 h (Figs. 6A,B). Inhibition of migration at the
initial transendothelial stage has previously been reported after
β2-integrin blockade. Thus, to test whether β2-integrins were
required for migration after this stage, antibody was added to the
lower chamber only. Adhesion was no longer reduced, indicating
that antibody did not access the cells in the upper chamber; there
was, however, some inhibition of transmigration (Figs. 6A,B).
These effects were similar for 4- and 20-day cultures. Analysis of
surface expression of integrins showed that after transmigration,
neutrophils had increased expression of CD18 compared to cells
incubated in tubes at 37 °C, although a similar increase was also
evident in neutrophils that had been retrieved from the upperFig. 4 – Comparison of transmigration of different leukocytes thro
and treatment with TNF for 4 h. The proportions of adherent leuko
the gel, for neutrophils (A,B), lymphocytes (C,D), mononuclear cell
more independent experiments with each type of cell. ANOVA show
(p<0.05), B (p<0.01) and D (p<0.01). *p<0.05, **p<0.01 for comchamber (Fig. 6C). Again, changes in expression were similar for
neutrophils that had been in contact with 4- or 20-day cultures.
Thus, β2-integrins appeared essential for initial migration through
endothelial monolayers, and also played a role in migration in the
subendothelial compartment regardless of the presence of BM.
Blockade of β1-integrins in the upper chamber had no effect on
neutrophil adhesion or migration indicating that constitutively-
expressed integrin did not play a role in any stage of migration
(Figs. 7A,B). To test whether newly-expressed integrin might be
effective, we added antibody to the lower chamber as well. In this
case, there was a reduction in transmigration for 4-day or 20-day
cultures (Fig. 7B) but not adhesion (Fig. 7A). This suggests that
β1-integrins were involved in subendothelial migration, whether
or not the BM was fully formed, but that pre-existing integrins on
the neutrophil surface were not responsible for this function.
However, when we analysed surface expression of β1-integrins
after transmigration, it was not significantly increased compared to
separately-incubated controls or cells washed off the HUVEC
monolayer (Fig. 7C). Since there was no net increase in β1-integrin
expression, we investigated whether there was any turnover of
integrins during migration. Neutrophils were pre-labelled with
unconjugated primary antibody before the migration assay, and
fluorescently-conjugated secondary antibody was added to cells
collected from the different compartments. The level of surface
expression detected was not significantly reduced for cells washed
off the HUVEC (MFI=88±5% of controls) but was slightly reduced
for transmigrated cells collected from the lower compartment
(MFI=79±5% of controls; p<0.05 by paired t-test) (mean±SEM
from 4 experiments). This indicates that some-pre-existing β1-
integrin was internalised during transmigration, and that there was
de novo surface expression at the same time, maintaining overall
surface expression approximately constant.
The roles of integrins inmigrationnoted abovewere similar for 4-
or 20-day cultures. Blockade of β3-integrins in the upper chamber
tended to reduce neutrophil migration slightly for 4- or 20-day
cultures, although this was not statistically significant (Fig. 8B).
Interestingly, when β3-integrins were blocked in both chambers,
neutrophil transmigration was significantly decreased specifically
through the 20 day cultures, while migration through the 4 day
cultures remained slightly but not significantly reduced. None of the
treatments affected the number of neutrophils adhering (Fig. 8A).
Examination of surface expression of β3-integrins revealed a pattern
similar to β1-integrins. There was no net increase in expression
during transmigration (Fig. 8C).Whenneutrophilswerepre-labelled
with unconjugated primary antibody, the level of expression
detected was not reduced for cells washed off the HUVEC
(MFI=102±4% of controls). Transmigrated cells collected from
the lower compartment tended to have lost some surface expression
(MFI=83±8% of controls) but this effect did not reach statistical
significance (p=0.08 by paired t-test) (mean±SEM from 7
experiments). These results indicate that β3-integrins only had a
marked role in subendothelial migration when the BM was fully
formed, and thiswas not attributable to integrins initially present on
the neutrophils.ugh HUVEC and into collagen gels after culture for 2 or 20 days
cytes were counted below the endothelial monolayer or within
s (E,F) or monocytes (G,H). Data are the mean±SEM from 3 or
ed a significant effect of culture duration on migration in A
parison between 4-day and 20-day cultures by paired t-test.
Fig. 6 – Function and expression of β2-integrins during
transmigration of neutrophils through TNF-treated HUVEC
cultured for 4 or 20 days. Effects of adding antibody against
β2-integrin to the upper chamber of Transwell filters (with
neutrophils) or the lower chamber only, on: (A) adhesion
to HUVEC; (B) transmigration; (C) surface expression of
β2-integrin on neutrophils retrieved from upper or lower
chambers (i.e., non-adherent or transmigrated neutrophils
respectively). Results for 4-day ( ) and 20-day ( )
cultures are shown, expressed relative to untreated control. In
A, data are the mean±SEM from 5 experiments. ANOVA
showed a significant effect of treatment of the upper chamber;
*p<0.05 compared to control by paired t-test. In B, data are the
mean±SEM from 5 experiments. ANOVA showed a significant
effect of treatment of either type; *p<0.05 compared to control
by paired t-test. In C, data are the mean±SEM from 3
experiments. ANOVA showed a significant effect of treatment
of either type, but there was no significant effect of treatment
for the individual days.
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integrins. When antibody against β1-integrins was combined
with antibody against β2-integrins (with the latter added only
to the lower chamber, to avoid its effects on the initial stages
of migration), transmigration was reduced slightly more than
for either antibody alone, and the effect was similar for 4-day or
20-day cultures (Fig. 9). When antibody against β3-integrin was
added as well, then there was a further reduction in transmigra-
tion, but now the effect was greater for 20-day cultures than 4-day
cultures (Fig. 9). Thus, again, β3-integrins had a greater role in
migration when BM was present.
Althoughvariousof the antibody treatments noted above,which
had no effect on migration, effectively acted as controls for those
that did, we also tested non-specific isotype-matched antibodies in
the assays. These antibodies had no significant effects on adhesion
or migration for 4-day or 20-day cultures (data not shown).
Effects of integrin blockade on migration directly observed
under flow
We made direct microscopic observations of antibody-treated
neutrophils migrating in a flow-based assay to check at which
stage of migration effects were observed. In earlier studies, we
found that antibodies against β2-integrins largely abolished stable
adhesion and migration of flowing neutrophils [8,34]. Here, pre-
treatment with the antibodies against β1- or β3-integrins (which
were present during the 4-minute perfusion of neutrophils but not
washout) had no detectable effect on levels of adhesion or of
transendothelial migration for 4-day or 20-day cultures (data not
shown). This agrees with our previous observations with short-
term cultures [23]. However, while neither antibody modified
migration velocity of neutrophils in the subendothelial space for
4-day cultures, the antibody against β3-integrins markedly reduced
the velocity of migration of the neutrophils under the 20-day
cultures (Fig. 10). The cells were observed not only to move more
slowly, but to take up more smoothly-rounded and less elongated
shapes. Antibody against β1-integrins had a lesser effect (Fig. 10)
with no obvious morphological change noted.
In these experiments, an antibody may have reached the
subendothelial compartment because filters were more vigorously
handled when being cut out and loaded in the flow chamber,
allowing more leakage than for intact filters. An antibody might
also washout gradually after perfusion of the cells. We thus tested
the effects of the small RGDS peptide which we could add to large
volumes of washout media. For 20-day cultures, the peptide had
an even greater effect on slowing migration than the antibody
against β3-integrins (Fig. 10), with many cells appearing spread
but with smooth outlines lacking pseudopodia. In contrast, there
was no discernible effect on behaviour under 4-day cultures
(Fig. 10). The peptide had no effects on levels of adhesion from
flow or on efficiency of transendothelial migration for either
duration of culture (data not shown).
Changes in basement membrane constituents over time and
adhesion of neutrophils to them
To evaluate whether the role of β3-integrin might arise from
changes in constituents in BM, we measured levels of specific
proteins by ELISA. Previously, we showed that concentration of
laminin, collagen type IV and fibronectin in a subendothelial
Fig. 7 – Function and expression of β1-integrins during
transmigration of neutrophils through TNF-treated HUVEC
cultured for 4 or 20 days. Effects of adding antibody against
β1-integrin to the upper chamber of Transwell filters (with
neutrophils) or the upper and lower chambers, on:
(A) adhesion to HUVEC; (B) transmigration; (C) surface
expression of β1-integrin on neutrophils retrieved from upper
or lower chambers (i.e., non-adherent or transmigrated
neutrophils respectively). Results for 4-day ( ) and 20-day
( ) cultures are shown, expressed relative to untreated
control. In A, data are themean±SEM from 5 experiments. In B,
data are the mean±SEM from 5 experiments. ANOVA showed a
significant effect of treatment of both chambers; **p<0.01
compared to control by paired t-test. In C, data are the mean±
SEM from 3 experiments.
Fig. 8 – Function and expression of β3-integrins during
transmigration of neutrophils through TNF-treated HUVEC
cultured for 4 or 20 days. Effects of adding antibody against
β3-integrin to the upper chamber of Transwell filters (with
neutrophils) or the upper and lower chamber only, on:
(A) adhesion to HUVEC; (B) transmigration; (C) surface
expression of β3-integrin on neutrophils retrieved from upper
or lower chambers (i.e., non-adherent or transmigrated
neutrophils respectively). Results are shown for 4-day ( )
and 20-day ( ) cultures, expressed relative to untreated
control. In A, data are themean±SEM from6 experiments. In B,
data are the mean±SEM from 6 experiments. ANOVA showed a
significant effect of treatment of the both chambers; *p<0.05
compared to control by paired t-test. In C, data are the mean±
SEM from 4 experiments.
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the β3-integrin ligand vitronectin and the specific laminin α4- and
α5-subunits. Vitronectin was barely detectable above the back-ground in a stripped matrix from 4-day cultures, and showed a
small but significant increase in day-20 BM (Fig. 11A). There was a
marked, significant increase in laminin between day-4 and day-20;
Fig. 9 – Effects of combinations of antibodies against integrins on
transmigration of neutrophils through TNF-treated HUVEC
cultured for 4 or 20 days. Antibodies against β1- and β3-integrins
were added to the upper and lower chambers, and antibody
against β2-integrin was added to the lower chambers only.
Results are shown for 4-day ( ) and 20-day ( ) cultures,
expressed relative to untreated control. Data are themean±SEM
from 4 experiments. **p<0.01 compared to control by paired
t-test. +p<0.05 for comparison between 4-day and 20-day
cultures by paired t-test.
Fig. 10 – Effects of inhibiting integrin function on migration
velocity of neutrophils after migration underneath HUVEC
cultured for 4 or 20 days. HUVEC were cultured for 4 or 20 days,
treated with 100 U/ml TNF for 4 h and transferred to a flow
chamber before perfusion of neutrophils for 4 min, followed by
washout. Migration velocity was measured between 11–16min
of washout. Antibody against β1-integrin ( ) or β3-integrin
( ) was added to neutrophils before perfusion, but was
absent from washout medium. RGDS peptide ( ) was added
to neutrophils before perfusion andwas also present inwashout
medium. Data are themean±SEMof themean velocities relative
to untreated controls from 3 experiments. *p<0.05, **p<0.01
compared to untreated cells by paired t-test.
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our previous studies), as well as the α4- and α5-subunits. The
signal from the α5-subunit was much lower than from the α4-
subunit at both times, especially considering that a much higher
antibody concentration was used to detect the former (see
Materials and methods).
To test the substrate-specificity of β3-integrins further, we
analysed adhesion of neutrophils treated with IL-8 to the stripped
matrix from 4-day or 20-day cultures and purified proteins.
Neither RGDS peptide nor antibody against β3-integrins reduced
adhesion to the 4-day matrix significantly; however both reduced
adhesion to the 20-day BM (Figs. 11B,C). For purified proteins,
RGDS peptide did not inhibit adhesion significantly to type IV
collagen or laminin from human placenta, but did inhibit adhesion
to purified fibronectin, and most effectively to vitronectin
(Fig. 11B). Antibody against β3-integrin tended to reduce binding
to fibronectin but this effect was not statistically significant;
binding to vitronectin was strongly inhibited (Fig. 11C).Discussion
We developed models in which human endothelial cells were
cultured on filters or gels for prolonged periods to deposit a
basement membrane. This enabled us to analyse leukocyte
migration through and under the EC, and then through the
basement membrane. By comparing kinetics of migration for
short-term and long-term cultures, we were able to show that the
basement membrane formed a distinct barrier to migration of
human neutrophils, delaying their progress away from the
subendothelial space. The hold-up in migration imposed by
basement membrane was evident in static or flow assays, and
was not specific to a particular inducer of migration. Indeed, thestripped basement membrane was itself a barrier to chemotaxis.
The barrier function was not so evident for migrating lymphocytes
or monocytes, although we could detect a slight delay in
lymphocyte migration into collagen gels for long-term cultures.
The studies not only revealed a distinct step in leukocytemigration
for human cells, but also delivered tractable models for studying
the roles of integrins in subendothelial migration of human
neutrophils which had not been clearly delineated previously.
We found that β2-integrins (but not β1- or β3-integrins) were
essential in the first stage of transendothelial migration, and also
contributed to subendothelial migration. β1-integrins also con-
tributed to migration in the subendothelial space. However, only
β3-integrins played a role specific to migration through basement
membrane, and for example, loss of motility under endothelium
was observed when their action was inhibited for 20-day but not
4-day cultures. This suggests that a specific interaction between
BM and β3-integrins is important in the penetration of this barrier
by neutrophils.
Transmigration of lymphocytes ormonocytes wasmuch slower
than neutrophils, judged by the transit through the filters or into
the gels. However, we and others have shown that migration
through the endothelial monolayer itself occurs in minutes for
lymphocytes, monocytes and neutrophils [33,35,36]. Clearly the
filter itself is a barrier to leukocyte migration, which is crossed
much more slowly for the mononuclear cells. In the case of
collagen gels, for short-term cultures neutrophils quickly dis-
persed into them. For lymphocytes, mixed mononuclear cells or
monocytes, even unobstructed entry into the gel was slower. The
Fig. 11 – Protein content ofmatrix fromHUVEC cultured for 4 or
20 days, and effects of integrin-inhibition on adhesion of
neutrophils to matrix or purified proteins. A. shows absorbance
values from ELISA for vitronectin (Vn), laminin (Lam), α4-chain
of laminin (Lam α4), α5-chain of laminin (Lam α5) on matrices
deposited by HUVEC after culture for 4 days ( ) or 20 days
( ). B. shows effect of RGDS peptide on adhesion of
neutrophils to 4-day or 20-day BM, collagen type IV (Coll),
laminin (Lam), fibronectin (Fn) or vitronectin (Vn). C. shows
effect of antibody against β3-integrin on adhesion to 4-day or
20-day BM, fibronectin (Fn) or vitronectin (Vn). In B and C,
adhesion is expressed relative to untreated control. Data are the
mean±SEM from 3 or more experiments. *p<0.05, **p<0.01
compared to 4-day inA, oruntreated control inB and C, bypaired
t-test.
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forth across endothelial monolayers, and the fact that many
lymphocytes remain associated with the endothelial monolayer
rather than migrating away, have been described previously
[33,36]. There thus seems to be a fundamental lack of signal(s)
to induce efficient subendothelial migration of mononuclear cells
in existing in vitro models. Therefore a caveat remains regarding
whether BM would be a more distinct barrier to their migration in
vivo when more effective signals for onward migration are present.
Nevertheless, recent observations of migration of neutrophils and
monocytes into thewall of post-capillary venules inmice do suggest
that theymay use a different mechanism to cross the BM [37]. Based
on our work, the BM itself seems less of a specific obstacle for
mononuclear cells than neutrophils.We previously analysed the subsets among peripheral blood
lymphocytes (PBL) that migrated in the trans-filter model using
immunostaining and flow cytometry [33,38]. We found that the
migrated cells contained the same proportions of CD4 and CD8
T-cells as the original PBL, and that in each case, there was
enrichment of the memory phenotype (CD45RA-negative) in the
migrated population. Using collagen gels in the current study, we
found that the proportions of CD4:CD8 cells was again similar for
cells retrieved from the gel as for the original PBL (data not
shown). Again, the proportion that were CD45RA-negative was
enriched in CD4 or CD8 cells in the gel, so that about 80% of
migrated CD4 or CD8 cells had this memory phenotype. Selectivity
for memory T-cells in transendothelial migration has been
reported previously for filter or gel models [39–42]. These results
suggest that slow migration away from the endothelial monolayer,
and the very modest hold-up due to basement membrane applies
to both the main T-cell memory subsets. Whether the same
phenomena apply to non-T-cell lymphocytes, or naive T-cells
homing through high-endothelial venules, cannot be addressed
through the current study. This might usefully be analysed by
selecting such cells from PBL and studying them in appropriate
culture models.
Long-term culture of EC alters their phenotype, as well as the
BM [16–18]. The cells are more sensitive to low dose TNF (judged
by the increased efficiency of neutrophil migration through the
monolayer itself) and develop a glycocalyx including hyaluronic
acid that supports this enhanced recruitment. However, in the
present study, attribution of the hold-up in neutrophil transmi-
gration to the BM itself is supported by several findings:
neutrophils migrated more slowly through stripped 20-day vs.
4-day BM alone; direct observations under flow showed a delay
between appearing under the endothelial monolayer and under
the BM/filter construct for 20-day vs. 4-day cultures; when the
same EC were seeded on 4-day or 20-day matrices for 2 further
days, neutrophil hold-up was seen for 20-day vs. 4-day matrices;
while it is possible that the re-seeded EC were themselves
modified by the different matrices, slowing of neutrophils
underneath re-seeded cells which were seen for 20-day vs. 4-
day [16], was reproduced on purified BM alone [17]; EC cultured
for 20 days had altered surface properties, but not expression (at
mRNA or protein levels) of adhesion molecules or chemokines
likely to influencemigration [18]; and changes over 20 days in the
EC layer itself were generally pro-migratory rather than inhibi-
tory, although only distinct at a low rather than high dose of TNF
[16]. Thus, overall, we conclude that it is safe to attribute the hold-
up in neutrophil migration to the basement membrane rather
than to any linked changes in endothelial cell phenotype.
The adhesive mechanism utilised by leukocytes after they have
crossed EC remain incompletely understood. A number of studies
have shown the importance of the β2-integrin (CD18) family in
neutrophils in the earlier stages of adhesion and transmigration
through the endothelial monolayer in static or flow-based models
in vitro [8,19,21,43], and in mice or rats in vivo [44,45]. In our own
work, their blockade inhibited immobilisation, so that rolling
continued and migration was essentially abolished [8,34]. Here,
blockade of β2-integrins in the upper compartment of filters
greatly reduced transmigration as expected, and we also con-
firmed previous reports of quantitative upregulation of CD11b
and/or CD18 during migration [25,46]. However, the current
studies described for the first time a role in migration in the
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‘behind’ the coated filters. That the antibody remained in the
subendothelial compartment was strongly suggested by the lack of
any change in adhesion to the endothelium in those assays, and
the much less efficient inhibition of migration compared to
addition to the upper compartment.
The role of β1-integrins in human neutrophil migration
through endothelium has been less clear. Intravital observations
in mice showed a requirement for upregulation of α6β1-integrin
for neutrophils to cross the basement membrane after migrating
through the endothelial cells [13]. The ability of β1-integrins to
take part in the binding of human neutrophils to matrix proteins
has been demonstrated in various studies including our own
[17,47–50], but most studies did not use EC-deposited matrix, and
the neutrophils themselves had not previously migrated through
endothelial cells. An earlier study found marked upregulation of
expression of β1-integrin, and an increase in their adhesive
function, for neutrophils that had undergone chemotaxis through
endothelial cells [51]. Recent studies showed that the transen-
dothelial migration process increased the motility of neutrophils
and modified their ability to use β1-integrins and αvβ3-integrin to
bind peptide substrates, but without evident changes in surface
expression [25]. Herewe found that pre-treatment with antibodies
against β1-integrins had no effect on transmigration across short-
or long-term endothelial monolayers in static or flow conditions,
but that addition of antibody to the subendothelial compartment
did inhibit egress from either type of culture. Total surface
expression did not change during migration, but we did obtain
evidence that there was turnover of β1-integrins, as transmigrated
cells showed loss of surface integrins labelled before the assay.
Thus, effects of antibody may have been mediated through
blockade of newly-exposed integrin, which played a role in
subendothelial migration, with or without the presence of fully-
formed BM.
To date there has been even less information on usage of β3-
integrins in neutrophil migration through endothelium. Intravital
studies in rats found that antibodies added to the vascular
compartment inhibited migration across endothelium when the
stimuluswas formyl peptide, but notwhen itwas IL-1 [52]. Itwasnot
clear where the hold-up was. With human cells, β3-integrins were
found to regulate migration on purified vitronectin [53], and their
blockade inhibited chemotaxis to formyl peptide through protein-
coated filters [54]. Our studies clearly indicate that β3-integrins are
involved in migration in the subendothelial space and through BM,
and that this is only evident for prolonged cultures. This explains
why we did not previously find any effects of blockade of this
integrin in transmigration studies where subendothelial migration
velocity was also analysed [23]. The ability of antibody and RGDS to
reduce migration velocity under EC or adhesion to stripped
subendothelial matrix, and marked effects on transmigration
through endothelial-filter constructs, were only observed for 20-
day cultures. In the filter transmigration model, effects were only
specific when antibody was added to the back of the filter. Antibody
blockade reduced subendothelial velocity for prolonged cultures in
the flowmodel, suggesting that in this system (which requiresmore
vigorous handling of the coated surface) antibody may have leaked
into subendothelial space more than in intact filters. RGDS was
effective in either system and this small peptide presumably gained
access to the sub-endotheliumrelatively easily. That it acted through
β3-integrins (forwhich it isnot strictly specific) in theseexperimentsis evidenced strongly by its lack of effect in 4-day cultures, either
viewed directly or in trans-filter assays, where β1- or β2-integrin
blockade should have had effects.
We did not detect net upregulation of β3-integrin expression
during transmigration, and there was only a slight loss of pre-
existing, surface-expressed integrin after transmigration. The fact
that addition of antibody to the subendothelial space, and the use
of peptide inhibitor, were particularly effective, nevertheless
suggest that there is turnover of this integrin during migration.
Cycling of integrins is widely considered to regulate cell
migration [55], but its role in controlling neutrophil recruitment
has not been specifically demonstrated. A problem with studying
turnover of both β3-integrin and β1-integrins in thesemodels was
that their levels of expression were relatively low (e.g., compared
to β2-integrins). This agrees with reports by others, who also
found that β3-integrins could take on a role in migration of
transmigrated neutrophils, even though difficult to detect by flow
cytometry [25].
It is likely that the development of the role of β3-integrins in
adhesion to andmigration through fully-formed BM arose because
of changes in its protein constituents. We previously showed
increased levels of laminin, fibronectin and collagen IV in day 20
versus day 4 matrix [16]. In neutrophils, β3-integrins have been
shown previously to regulate migration on vitronectin and
fibronectin [53,56]. Here, RGDS peptide and antibody against β3-
integrin inhibited adhesion to both purified proteins, although
more efficiently for vitronectin. In endothelial matrices, we could
barely detect vitronectin after 4 days by ELISA, and there was a
slight increase in signal after 20 days. We also analysed changes in
the main endothelial laminin isoforms, laminin 411 and laminin
511, using ELISA specific for the different α4- and α5-chains.
Laminin 411 has been shown to support neutrophil migration via
β1- and β2-integrins [e.g., 57,58], but laminin 511 can support
interaction with other cell types at least through RGD-dependent
or β3-integrin interactions [59,60]. We found that the α4-chain
was easily detectable and increased with culture duration. Theα5-
chain was not detectable in the 4-day matrix using the same
antibody concentration as for the α4-chain, but could be detected
if a much higher concentration was used. In that case, we saw a
several-fold increase after 20-day culture compared to 4-day. Thus
two potential β3-integrin ligands, vitronectin and laminin 511,
were present only at levels near the detection limit of the ELISA
after 4 days and increased significantly by 20 days. It is possible
that only by the later time had they reached critical levels to
support integrin-binding that had functional effects. Further
definition of the specific roles of these and other matrix proteins
would require use of antibodies specific for their integrin-binding
sites, ormethods formanipulating their expression over prolonged
periods in endothelial cells.
The above raises questions as to the signals which caused
changes in integrin function during transmigration. Ligation of
CD31 has been shown tomodify adhesive functions of β1-integrins
and β2-integrins [61,62], and increases neutrophil motility under
EC in our hands [23]. In mice, ligation of CD31 was required for
upregulation of expression of α6β1-integrin and thus CD31
indirectly affected the ability of neutrophils to cross BM [13].
However, previously we found no effect of antibody blockade of
CD31 on migration from the subendothelial space through filters
under flow [26]. Similar antibody treatment in the current model
showed no effect onmigration through filters coatedwith 4-day or
290 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 7 ( 2 0 1 1 ) 2 7 6 – 2 9 220-day cultures (data not shown). Nor could we detect any
upregulation of the α6-integrin subunit when transmigrated
neutrophils were analysed by flow cytometry (data not shown).
Contact with the BM itself seems to modify neutrophil behaviour.
In the flow model, neutrophils underneath EC migrated more
slowly for long-term than short-term cultures. This agrees with
previous observations [16,17],where we also found isolated BM to
slow neutrophil migration compared to substrate from short-term
cultures or deposited purified BM proteins such as laminin,
collagen or fibronectin. An interesting possibility is that the role
of β3-integrin was itself regulatory rather than directly adhesive.
We found that β1- andβ2-integrins were required to adhere to
stripped basement membrane [17] and both clearly influenced
subendothelial migration in the current study. Blockade of β3-
integrin in the present study had a partial effect on adhesion to
stripped BM at 20 days but not 4 days, although it is likely that
adequate ligands for the other integrins were present at the later
time. In a previous study, we found that β3-integrins regulated the
direction of neutrophil migration in flow, although not required
for adhesion to the substrate, which was supported by β2-
integrins [56]. Thus interaction between β3-integrins and compo-
nent(s) in the mature BM may regulate the adhesive and
migratory functions supported through the other integrins.
Overall, our studies support the concept that migration from
the subendothelial space, through basement membrane is a
distinct step in the recruitment of leukocytes, which is differently
regulated for different leukocyte subsets. They also reveal
contributions from β1-, β2- and β3-integrins to migration during
this step, but perhaps most interestingly, that β3-integrins are
specifically engaged in migration on, and through, basement
membrane. The models described here will be useful for further
analysis of adhesive mechanisms utilised by human leukocytes in
the later stages of recruitment. It has recently been suggested that
leukocyte integrins are not needed for migration through tissue
matrix [22], although the above indicates that this is not the case
for the subendothelial stage. Neither use of purified proteins, or
of collagen or similar gels alone, are adequate for modelling
this behaviour, because the subsequent migratory behaviour of
neutrophils changes during transendothelial migration [16,23,25],
and the present studies show that collagen gel alone does not
provide the same migration barrier as proteins deposited by EC
over time. Integrated models where leukocytes can be followed
through the various steps in sequence are required to obtain a full
picture of the regulatory mechanism operating at each stage.
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